Home › Funds › ACUTA CAPITAL PARTNERS, LLC › QNCX
ACUTA CAPITAL PARTNERS, LLC position in QNCX
QUINCE THERAPEUTICS INC · Health Care
ACUTA CAPITAL PARTNERS, LLC reported holding 52,918 shares of QNCX (QUINCE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 1.29% of its reported portfolio and ranking #22 among its reported holdings. ACUTA CAPITAL PARTNERS, LLC first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ACUTA CAPITAL PARTNERS, LLC's QNCX position evolved
ACUTA CAPITAL PARTNERS, LLC first disclosed a stake in QNCX in Q3 2026 at 52,918 shares (US$1.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 52.92K | $1.64M | New |
About QNCX and 13F data
QNCX (QUINCE THERAPEUTICS INC) is a Health Care company. 17 other funds we track also report a position in QNCX — the largest reported positions include Birchview Capital, LP (US$1.3M), Squadron Capital Management LLC (US$734K), Cormorant Asset Management, LP (US$100K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding QNCX
- Birchview Capital, LP 40.60K sh · $1.26M · Q3 2026
- Squadron Capital Management LLC 40.38K sh · $734.42K · Q2 2026
- Cormorant Asset Management, LP 5.50K sh · $100.01K · Q2 2026
More on ACUTA CAPITAL PARTNERS, LLC
FAQ
How long has ACUTA CAPITAL PARTNERS, LLC held QNCX?
ACUTA CAPITAL PARTNERS, LLC has disclosed QNCX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ACUTA CAPITAL PARTNERS, LLC's current position in QNCX?
As of Q3 2026, ACUTA CAPITAL PARTNERS, LLC holds 52.92K shares of QNCX (QUINCE THERAPEUTICS INC), valued at $1.64M, representing 1.29% of its reported portfolio and ranking #22.
Has ACUTA CAPITAL PARTNERS, LLC been buying or selling QNCX?
In the latest 13F filing (Q3 2026), ACUTA CAPITAL PARTNERS, LLC newly opened its position in QNCX.
Which other funds hold QNCX?
Other major institutional holders of QNCX include Birchview Capital, LP, Squadron Capital Management LLC, Cormorant Asset Management, LP, among 17 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.